Advertisement
Screener

UNIGENE LABORATORIES INC Interest Expense

UNIGENE LABORATORIES INC Interest Expense

UNIGENE LABORATORIES INC reported Interest Expense of $4.52 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2013-05-14

  • UNIGENE LABORATORIES INC interest expense for the quarter ending 2013-03-31 was $4.52M, a 57.69% increase year-over-year.
  • UNIGENE LABORATORIES INC interest expense for the quarter ending 2012-12-31 was $4.24M, a 67.09% increase year-over-year.
  • UNIGENE LABORATORIES INC interest expense for the quarter ending 2012-09-30 was $3.47M, a 23.08% increase year-over-year.
  • UNIGENE LABORATORIES INC interest expense for the quarter ending 2012-06-30 was $3.28M, a 22.01% increase year-over-year.
  • UNIGENE LABORATORIES INC interest expense for fiscal 2012 was $13.86M, a 32.19% increase from fiscal 2011.
  • UNIGENE LABORATORIES INC interest expense for fiscal 2011 was $10.48M, a 30.42% increase from fiscal 2010.
  • UNIGENE LABORATORIES INC interest expense for fiscal 2010 was $8.04M, a 65.32% increase from fiscal 2009.
  • UNIGENE LABORATORIES INC interest expense for fiscal 2009 was $4.86M.
Period endInterest Expense 3 monthInterest Expense 3 month as first filedInterest Expense 6 monthInterest Expense 6 month as first filedInterest Expense 9 monthInterest Expense 9 month as first filedInterest Expense 12 monthInterest Expense 12 month as first filed
2013-03-31$4.52M
10-Q · filed 2013-05-14
$8.77M
derived: sum of 2 quarters · filed 2013-05-14
$12.23M
derived: sum of 3 quarters · filed 2013-05-14
$15.51M
derived: sum of 4 quarters · filed 2013-05-14
2012-12-31$4.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$7.71M
derived: sum of 2 quarters · filed 2013-03-15
$10.99M
derived: sum of 3 quarters · filed 2013-03-15
$13.86M
10-K · filed 2013-03-15
2012-09-30$3.47M
10-Q · filed 2013-01-31
$6.75M
derived: sum of 2 quarters · filed 2013-01-31
$9.61M
10-Q · filed 2013-01-31
$12.15M
derived: sum of 4 quarters · filed 2013-05-14
2012-06-30$3.28M
10-Q/A · filed 2013-01-31
$2.94M
10-Q · filed 2012-08-09
$6.15M
10-Q/A · filed 2013-01-31
$5.71M
10-Q · filed 2012-08-09
$8.69M
derived: sum of 3 quarters · filed 2013-05-14
$11.50M
derived: sum of 4 quarters · filed 2013-05-14
2012-03-31$2.87M
10-Q · filed 2013-05-14
$2.76M
10-Q · filed 2012-05-10
$5.41M
derived: sum of 2 quarters · filed 2013-05-14
$8.22M
derived: sum of 3 quarters · filed 2013-05-14
$10.91M
derived: sum of 4 quarters · filed 2013-05-14
2011-12-31$2.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$5.36M
derived: sum of 2 quarters · filed 2013-03-15
$8.05M
derived: sum of 3 quarters · filed 2013-03-15
$10.48M
10-K · filed 2013-03-15
$10.92M
10-K · filed 2012-03-15
2011-09-30$2.82M
10-Q · filed 2013-01-31
$2.86M
10-Q · filed 2011-11-09
$5.51M
derived: sum of 2 quarters · filed 2013-01-31
$7.94M
10-Q · filed 2013-01-31
$8.40M
10-Q · filed 2011-11-09
$9.24M
derived: sum of 4 quarters · filed 2013-03-15
2011-06-30$2.69M
10-Q/A · filed 2013-01-31
$2.80M
10-Q · filed 2011-08-09
$5.13M
10-Q/A · filed 2013-01-31
$5.53M
10-Q · filed 2011-08-09
$6.43M
derived: sum of 3 quarters · filed 2013-03-15
$9.05M
derived: sum of 4 quarters · filed 2013-03-15
2011-03-31$2.44M
10-Q/A · filed 2013-01-31
$2.74M
10-Q · filed 2012-05-10
$3.74M
derived: sum of 2 quarters · filed 2013-03-15
$6.36M
derived: sum of 3 quarters · filed 2013-03-15
$8.95M
derived: sum of 4 quarters · filed 2013-03-15
2010-12-31$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$3.92M
derived: sum of 2 quarters · filed 2013-03-15
$6.52M
derived: sum of 3 quarters · filed 2013-03-15
$8.04M
10-K · filed 2013-03-15
$9.29M
10-K · filed 2012-03-15
2010-09-30$2.62M
10-Q · filed 2011-11-09
$5.22M
derived: sum of 2 quarters · filed 2011-11-09
$6.74M
10-Q · filed 2011-11-09
2010-06-30$2.60M
10-Q · filed 2011-08-09
$4.12M
10-Q · filed 2011-08-09
2009-12-31$4.86M
10-K/A · filed 2013-01-31